Showing results (101-110 of 195) with videos related to

Sort By:
Pageof 20
British Journal of Cancer|December 1, 2004
The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesionsG Terry, L Ho, P Londesborough, et al.
The British Journal of Surgery|January 3, 2001
High-risk colorectal adenomas and serum insulin-like growth factorsA G Renehan, J E Painter, W S Atkin, et al.
Lancet (London, England)|September 17, 1988
Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change?S E Barton, P H Maddox, D Jenkins, et al.
British Journal of Haematology|August 1, 1990
Long-term prognostic value of serum beta 2 microglobulin in myelomatosisJ Cuzick, B L De Stavola, E H Cooper, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1987
A trial of human alpha interferon as an adjuvant agent in breast cancer after loco-regional recurrenceI S Fentiman, F R Balkwill, J Cuzick, et al.
Cancer|October 30, 2003
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analysesM Baum, A Buzdar, J Cuzick, et al.
British Journal of Cancer|November 13, 2008
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancerB Sherrill, M Amonkar, Y Wu, et al.
Lancet (London, England)|May 22, 2007
Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials, J Cuzick, L Ambroisine, et al.
Lancet (London, England)|February 1, 2003
Overview of the main outcomes in breast-cancer prevention trialsJ Cuzick, T Powles, U Veronesi, et al.
International Journal of Cancer|March 3, 1995
Risk of ocular melanoma in relation to cutaneous and iris naeviV Bataille, P Sasieni, J Cuzick, et al.
Pageof 20